Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker RMD
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | Michael J. Farrell Chairman and CEO, Director | RMD ResMed Inc. | Sale | 4,993 | $235.35 | $1.2M Sale | Form 4 ↗ |
| Oct 23, 2026 | Michael J. Rider Global General Counsel | RMD ResMed Inc. | Sale | 400 | $255.00 | $102.0K Sale | Form 4 ↗ |
| Sep 8, 2026 | Michael J. Farrell Chairman and CEO, Director | RMD ResMed Inc. | Sale | 4,991 | $222.44 | $1.1M Sale | Form 4 ↗ |
| Sep 2, 2026 | Peter C. Farrell Director | RMD ResMed Inc. | Sale | 970 | $234.73 | $227.7K Sale | Form 4 ↗ |
| Aug 7, 2026 | Michael J. Farrell Chairman and CEO, Director | RMD ResMed Inc. | Sale | 4,991 | $205.69 | $1.0M Sale | Form 4 ↗ |
| Aug 5, 2026 | Peter C. Farrell Director | RMD ResMed Inc. | Sale | 8,000 | $225.00 | $1.8M Sale | Form 4 ↗ |
| Jul 7, 2026 | Michael J. Farrell Chairman and CEO, Director | RMD ResMed Inc. | Sale | 4,991 | $218.55 | $1.1M Sale | Form 4 ↗ |
| Jun 8, 2026 | Michael J. Farrell Chairman and CEO, Director | RMD ResMed Inc. | Sale | 4,991 | $193.96 | $968.1K Sale | Form 4 ↗ |
| May 7, 2026 | Michael J. Farrell Chairman and CEO, Director | RMD ResMed Inc. | Sale | 4,991 | $207.82 | $1.0M Sale | Form 4 ↗ |
| Apr 7, 2026 | Michael J. Farrell Chairman and CEO, Director | RMD ResMed Inc. | Sale | 4,991 | $225.50 | $1.1M Sale | Form 4 ↗ |
| Apr 1, 2026 | Brett Sandercock Chief Financial Officer | RMD ResMed Inc. | Sale | 1,000 | $224.31 | $224.3K Sale | Form 4 ↗ |
| Apr 1, 2026 | Peter C. Farrell Director | RMD ResMed Inc. | Sale | 2,000 | $225.00 | $450.0K Sale | Form 4 ↗ |
| Mar 9, 2026 | Michael J. Farrell Chairman and CEO, Director | RMD ResMed Inc. | Sale | 4,991 | $251.03 | $1.3M Sale | Form 4 ↗ |
| Mar 4, 2026 | Peter C. Farrell Director | RMD ResMed Inc. | Sale | 2,000 | $260.22 | $520.4K Sale | Form 4 ↗ |
| Mar 2, 2026 | Brett Sandercock Chief Financial Officer | RMD ResMed Inc. | Sale | 1,000 | $254.30 | $254.3K Sale | Form 4 ↗ |
| Feb 9, 2026 | Michael J. Farrell Chairman and CEO, Director | RMD ResMed Inc. | Sale | 4,991 | $273.78 | $1.4M Sale | Form 4 ↗ |
| Feb 4, 2026 | Peter C. Farrell Director | RMD ResMed Inc. | Sale | 2,000 | $251.31 | $502.6K Sale | Form 4 ↗ |
| Feb 4, 2026 | Michael J. Rider Global General Counsel | RMD ResMed Inc. | Sale | 50 | $260.00 | $13.0K Sale | Form 4 ↗ |
| Feb 2, 2026 | Brett Sandercock Chief Financial Officer | RMD ResMed Inc. | Sale | 1,000 | $257.03 | $257.0K Sale | Form 4 ↗ |
| Jan 7, 2026 | Peter C. Farrell Director | RMD ResMed Inc. | Sale | 2,000 | $248.83 | $497.7K Sale | Form 4 ↗ |
| Jan 7, 2026 | Michael J. Farrell Chairman and CEO, Director | RMD ResMed Inc. | Sale | 4,991 | $248.46 | $1.2M Sale | Form 4 ↗ |
| Jan 2, 2026 | Brett Sandercock Chief Financial Officer | RMD ResMed Inc. | Sale | 1,000 | $241.75 | $241.8K Sale | Form 4 ↗ |
| Jan 2, 2026 | Michael J. Rider Global General Counsel | RMD ResMed Inc. | Sale | 50 | $241.75 | $12.1K Sale | Form 4 ↗ |
| Dec 8, 2025 | Michael J. Farrell Chairman and CEO, Director | RMD ResMed Inc. | Sale | 4,991 | $251.41 | $1.3M Sale | Form 4 ↗ |
| Dec 3, 2025 | Peter C. Farrell Director | RMD ResMed Inc. | Sale | 2,000 | $251.47 | $502.9K Sale | Form 4 ↗ |
| Dec 1, 2025 | Michael J. Rider Global General Counsel | RMD ResMed Inc. | Sale | 50 | $244.16 | $12.2K Sale | Form 4 ↗ |
| Dec 1, 2025 | Brett Sandercock Chief Financial Officer | RMD ResMed Inc. | Sale | 1,000 | $244.16 | $244.2K Sale | Form 4 ↗ |
| Nov 25, 2025 | Jan De Witte Director | RMD ResMed Inc. | Sale | 2,055 | $255.00 | $524.0K Sale | Form 4 ↗ |
| Nov 12, 2025 | Peter C. Farrell Director | RMD ResMed Inc. | Sale | 2,000 | $252.05 | $504.1K Sale | Form 4 ↗ |
| Nov 11, 2025 | Jan De Witte Director | RMD ResMed Inc. | Sale | 487 | $250.25 | $121.9K Sale | Form 4 ↗ |
| Nov 7, 2025 | Michael J. Farrell Chairman and CEO, Director | RMD ResMed Inc. | Sale | 8,011 | $249.75 | $2.0M Sale | Form 4 ↗ |
| Nov 3, 2025 | Brett Sandercock Chief Financial Officer | RMD ResMed Inc. | Sale | 3,000 | $247.54 | $742.6K Sale | Form 4 ↗ |
| Oct 7, 2025 | Michael J. Farrell Chief Executive Officer | RMD ResMed Inc. | Sale | 8,009 | $282.85 | $2.3M Sale | Form 4 ↗ |
| Oct 1, 2025 | Brett Sandercock Chief Financial Officer | RMD ResMed Inc. | Sale | 3,000 | $274.36 | $823.1K Sale | Form 4 ↗ |
| Oct 1, 2025 | Michael J. Rider Global General Counsel | RMD ResMed Inc. | Sale | 100 | $274.36 | $27.4K Sale | Form 4 ↗ |
| Sep 8, 2025 | Michael J. Farrell Chief Executive Officer | RMD ResMed Inc. | Sale | 8,009 | $278.14 | $2.2M Sale | Form 4 ↗ |
| Sep 2, 2025 | Brett Sandercock Chief Financial Officer | RMD ResMed Inc. | Sale | 3,000 | $270.77 | $812.3K Sale | Form 4 ↗ |
| Aug 18, 2025 | John Hernandez Director | RMD ResMed Inc. | Sale | 2,575 | $287.10 | $739.3K Sale | Form 4 ↗ |
| Aug 7, 2025 | Michael J. Farrell Chief Executive Officer | RMD ResMed Inc. | Sale | 8,009 | $279.48 | $2.2M Sale | Form 4 ↗ |
| Aug 1, 2025 | Brett Sandercock Chief Financial Officer | RMD ResMed Inc. | Sale | 3,000 | $281.90 | $845.7K Sale | Form 4 ↗ |
| Aug 1, 2025 | Michael J. Rider Global General Counsel | RMD ResMed Inc. | Sale | 50 | $281.90 | $14.1K Sale | Form 4 ↗ |
| Jul 7, 2025 | Michael J. Farrell Chief Executive Officer | RMD ResMed Inc. | Sale | 8,009 | $256.72 | $2.1M Sale | Form 4 ↗ |
| Jul 2, 2025 | Peter C. Farrell Director | RMD ResMed Inc. | Sale | 945 | $255.49 | $241.4K Sale | Form 4 ↗ |
| Jul 1, 2025 | Brett Sandercock Chief Financial Officer | RMD ResMed Inc. | Sale | 3,883 | $256.99 | $997.9K Sale | Form 4 ↗ |
| Jul 1, 2025 | Michael J. Rider Global General Counsel | RMD ResMed Inc. | Sale | 66 | $256.99 | $17.0K Sale | Form 4 ↗ |
| Jun 9, 2025 | Michael J. Farrell Chief Executive Officer | RMD ResMed Inc. | Sale | 8,009 | $251.21 | $2.0M Sale | Form 4 ↗ |
| Jun 4, 2025 | Peter C. Farrell Director | RMD ResMed Inc. | Sale | 2,000 | $247.32 | $494.6K Sale | Form 4 ↗ |
| Jun 2, 2025 | Michael J. Rider Global General Counsel | RMD ResMed Inc. | Sale | 41 | $243.78 | $9,995 Sale | Form 4 ↗ |
| Jun 2, 2025 | Brett Sandercock Chief Financial Officer | RMD ResMed Inc. | Sale | 1,000 | $243.78 | $243.8K Sale | Form 4 ↗ |
| May 22, 2025 | Brett Sandercock Chief Financial Officer | RMD ResMed Inc. | Sale | 3,644 | $244.59 | $891.3K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:38 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances